CORT
Corcept Therapeutics Incorporated · Healthcare · Medical - Pharmaceuticals
Señales de momentum (gestores comparables):
amplitud de titulares +7.7% ·
flujo de acciones -4.2% ·
nuevas posiciones netas +7.1%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 115 | +10 | 52.54M | $4.56B | +17 | −6 |
| Q1 2026 | 107 | -4 | 51.80M | $2.09B | +8 | −13 |
| Q4 2025 | 112 | 0 | 56.18M | $1.96B | +1 | — |
| Q3 2025 | 18 | -2 | 41.55M | $3.45B | +1 | −4 |
| Q2 2025 | 18 | +1 | 38.50M | $2.83B | +1 | — |
| Q1 2025 | 14 | +1 | 15.71M | $1.80B | +1 | — |
| Q4 2024 | 13 | 0 | 16.40M | $826.20M | — | — |
| Q3 2024 | 12 | -1 | 13.66M | $632.44M | — | −1 |
| Q2 2024 | 13 | — | 13.78M | $447.82M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 6.14M | -0.9% | $701.66M | 1.1% | ▼ Trim | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasivo) | 3.40M | -4.1% | $388.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 2.26M | +9.3% | $258.99M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 2.26M | +9.3% | $258.99M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Arrowstreet Capital ✦ | 1.49M | -9.3% | $170.44M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 6 | Norges Bank ✦ (pasivo) | 848.90K | +1.7% | $96.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 700.26K | -21.0% | $79.98M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 700.26K | -21.0% | $79.98M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 9 | Millennium Management ✦ | 281.96K | -44.5% | $32.21M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 253.03K | -8.5% | $28.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 253.03K | -8.5% | $28.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 253.03K | -8.5% | $28.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 253.03K | -8.5% | $28.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 253.03K | -8.5% | $28.90M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 180.15K | -11.1% | $20.58M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 64.89K | +18.5% | $7.41M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 17 | Wellington Management ✦ | 35.51K | -5.9% | $4.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Wellington Management ✦ | 35.51K | -5.9% | $4.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Wellington Management ✦ | 35.51K | -5.9% | $4.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Wellington Management ✦ | 35.51K | -5.9% | $4.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 28.26K | -75.5% | $3.23M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 28.26K | -75.5% | $3.23M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 17.42K | -9.0% | $1.99M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Marshall Wace ✦ | 5.16K | Nuevo | $589,376 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $589,376 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 347 tenedores, 79.01M acciones, $2.83B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 4.98K acc. · $585,478
Director · 91.17K acc. · $10.78M
Director · 7.05K acc. · $838,710
Director · 400 acc. · $47,855
Officer · 10.00K acc. · $1.16M
Director · 3.05K acc. · $337,341
Director · 4.67K acc. · $520,214
Director · 2.28K acc. · $256,706
Officer · 3.66K acc. · $419,491
Officer · 11.53K acc. · $1.30M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología